SCHEMBL25476268

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL25913789	0.93	SMN1; SMN2 (0.33)	ALDH1A1HPGDGAASMN1; SMN2MAPT
	SCHEMBL25737072	0.89	—	—
	SCHEMBL25476266	0.88	NPC1 (0.31)	RAB9A
	SCHEMBL25528042	0.88	SMN1; SMN2 (0.33)	ALDH1A1HPGDGAASMN1; SMN2MAPT
	SCHEMBL25476263	0.86	—	—
	SCHEMBL25913787	0.82	—	—
	SCHEMBL25913793	0.81	—	—
	SCHEMBL25476276	0.79	—	—
	SCHEMBL19756104	0.78	ALDH1A1 (0.39)	ALDH1A1HPGDGAASMN1; SMN2MAPT
	SCHEMBL25527951	0.78	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.